Ident. | Authors (with country if any) | Title |
---|
000083 (2020) |
Xiao-Li Qiang ; Peng Xu ; Gang Fang ; Wen-Bin Liu ; Zheng Kou | Using the spike protein feature to predict infection risk and monitor the evolutionary dynamic of coronavirus |
000199 (2020) |
Jian Shang [États-Unis] ; Yushun Wan [États-Unis] ; Chang Liu [États-Unis] ; Boyd Yount [États-Unis] ; Kendra Gully [États-Unis] ; Yang Yang [États-Unis] ; Ashley Auerbach [États-Unis] ; Guiqing Peng [République populaire de Chine] ; Ralph Baric [États-Unis] ; Fang Li [États-Unis] | Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry. |
000202 (2020) |
Mushtaq Hussain [Pakistan] ; Nusrat Jabeen [Pakistan] ; Fozia Raza [Pakistan] ; Sanya Shabbir [Pakistan] ; Ayesha A. Baig [Pakistan] ; Anusha Amanullah [Pakistan] ; Basma Aziz [Pakistan] | Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. |
000214 (2020) |
Junwen Luan [République populaire de Chine] ; Yue Lu [République populaire de Chine] ; Xiaolu Jin [République populaire de Chine] ; Leiliang Zhang [République populaire de Chine] | Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection |
000222 (2020) |
Kun Li [États-Unis] ; Zhuo Li [États-Unis] ; Christine Wohlford-Lenane [États-Unis] ; David K. Meyerholz [États-Unis] ; Rudragouda Channappanavar [États-Unis] ; Dong An [États-Unis] ; Stanley Perlman [États-Unis] ; Paul B. Mccray [États-Unis] ; Biao He [États-Unis] | Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection |
000290 (2020) |
Joseph Thomas Ortega [États-Unis] ; Maria Luisa Serrano [Venezuela] ; Flor Helene Pujol [Venezuela] ; Hector Rafael Rangel [Venezuela] | Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis |
000296 (2020) |
Gerard Kian-Meng Goh [Singapour] ; A. Keith Dunker ; James A. Foster [États-Unis] ; Vladimir N. Uversky [États-Unis, Russie] | Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity |
000393 (2020) |
Wen-Hsiang Chen [États-Unis] ; Peter J. Hotez [États-Unis] ; Maria Elena Bottazzi [États-Unis] | Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19. |
000400 (2020) |
Xiaolong Tian [République populaire de Chine] ; Cheng Li [République populaire de Chine] ; Ailing Huang [République populaire de Chine] ; Shuai Xia [République populaire de Chine] ; Sicong Lu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Lu Lu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] ; Zhenlin Yang [République populaire de Chine] ; Yanling Wu [République populaire de Chine] ; Tianlei Ying [République populaire de Chine] | Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. |
000541 (2020) |
Shuai Xia [République populaire de Chine] ; Meiqin Liu [République populaire de Chine] ; Chao Wang [République populaire de Chine] ; Wei Xu [République populaire de Chine] ; Qiaoshuai Lan [République populaire de Chine] ; Siliang Feng [République populaire de Chine] ; Feifei Qi [République populaire de Chine] ; Linlin Bao [République populaire de Chine] ; Lanying Du [États-Unis] ; Shuwen Liu [République populaire de Chine] ; Chuan Qin [République populaire de Chine] ; Fei Sun [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Yun Zhu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine, États-Unis] ; Lu Lu [République populaire de Chine] | Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion |
000558 (2020) |
Phulen Sarma [Inde] ; Nishant Sekhar [Inde] ; Manisha Prajapat [Inde] ; Pramod Avti [Inde] ; Hardeep Kaur [Inde] ; Subodh Kumar [Inde] ; Sanjay Singh [Inde] ; Harish Kumar [Inde] ; Ajay Prakash [Inde] ; Deba Prasad Dhibar [Inde] ; Bikash Medhi [Inde] | In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). |
000602 (2020) |
Hanako Sekimukai [Japon] ; Naoko Iwata-Yoshikawa [Japon] ; Shuetsu Fukushi [Japon] ; Hideki Tani [Japon] ; Michiyo Kataoka [Japon] ; Tadaki Suzuki [Japon] ; Hideki Hasegawa [Japon] ; Kenichi Niikura [Japon] ; Katsuhiko Arai [Japon] ; Noriyo Nagata [Japon] | Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs. |
000652 (2020) |
Domenico Benvenuto [Italie] ; Silvia Angeletti [Italie] ; Marta Giovanetti [Brésil] ; Martina Bianchi [Italie] ; Stefano Pascarella [Italie] ; Roberto Cauda [Italie] ; Massimo Ciccozzi [Italie] ; Antonio Cassone [Italie] | Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy. |
000654 (2020) |
Xintian Xu [République populaire de Chine] ; Ping Chen [République populaire de Chine] ; Jingfang Wang [République populaire de Chine] ; Jiannan Feng [République populaire de Chine] ; Hui Zhou [République populaire de Chine] ; Xuan Li [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Pei Hao [République populaire de Chine] | Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. |
000800 (2020) |
Chu-Wen Yang [Taïwan] ; Mei-Fang Chen [Taïwan] | Composition of human-specific slow codons and slow di-codons in SARS-CoV and 2019-nCoV are lower than other coronaviruses suggesting a faster protein synthesis rate of SARS-CoV and 2019-nCoV. |
000807 (2020) |
Bruno Tilocca [Italie] ; Alessio Soggiu [Italie] ; Maurizio Sanguinetti [Italie] ; Vincenzo Musella [Italie] ; Domenico Britti [Italie] ; Luigi Bonizzi [Italie] ; Andrea Urbani [Italie] ; Paola Roncada [Italie] | Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses |
000953 (2020) |
B. Robson | COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles’ heel conserved region to minimize probability of escape mutations and drug resistance |
000A01 (2020) |
Yair Cárdenas-Conejo [Mexique] ; Andr Meda Li An-Rico [Mexique] ; Daniel Alejandro García-Rodríguez [Mexique] ; Sara Centeno-Leija [Mexique] ; Hugo Serrano-Posada [Mexique] | An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human-pathogenic coronavirus (SARS-CoV-2). |
000A16 (2020) |
Rhian M. Touyz [Royaume-Uni] ; Hongliang Li [République populaire de Chine] ; Christian Delles [Royaume-Uni] | ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19. |
000A92 (2019) |
Shiu-Mei Wang [Taïwan] ; Kuo-Jung Huang [Taïwan] ; Chin-Tien Wang [Taïwan] | Severe acute respiratory syndrome coronavirus spike protein counteracts BST2-mediated restriction of virus-like particle release. |
000A98 (2019) |
Garret N. Gomez [États-Unis] ; Fareeha Abrar [États-Unis] ; Maya P. Dodhia [États-Unis] ; Fabiola G. Gonzalez [États-Unis] ; Anita Nag [États-Unis] | SARS coronavirus protein nsp1 disrupts localization of Nup93 from the nuclear pore complex. |
000B64 (2019) |
Dewald Schoeman ; Burtram C. Fielding | Coronavirus envelope protein: current knowledge |
000B84 (2019) |
Jiwon Woo [Corée du Sud] ; Eunice Yoojin Lee [États-Unis] ; Mirae Lee [Corée du Sud] ; Taeyeon Kim [Corée du Sud] ; Yong-Eun Cho [Corée du Sud] | An in vivo cell-based assay for investigating the specific interaction between the SARS-CoV N-protein and its viral RNA packaging sequence. |
000B92 (2019) |
Zhou Shen [République populaire de Chine] ; Gang Wang [République populaire de Chine] ; Yiling Yang [République populaire de Chine] ; Jiale Shi [République populaire de Chine] ; Liurong Fang [République populaire de Chine] ; Fang Li [États-Unis] ; Shaobo Xiao [République populaire de Chine] ; Zhen F. Fu [République populaire de Chine, États-Unis] ; Guiqing Peng [République populaire de Chine] | A conserved region of nonstructural protein 1 from alphacoronaviruses
inhibits host gene expression and is critical for viral
virulence |
000C52 (2018) |
Yifeng Chen [République populaire de Chine] ; Zhibang Zhang [République populaire de Chine] ; Jie Li [République populaire de Chine] ; Yueyi Gao [République populaire de Chine] ; Lei Zhou [République populaire de Chine] ; Xinna Ge [République populaire de Chine] ; Jun Han [République populaire de Chine] ; Xin Guo [République populaire de Chine] ; Hanchun Yang [République populaire de Chine] | Porcine epidemic diarrhea virus S1 protein is the critical inducer of apoptosis |
000C56 (2018) |
Wei-Chen Hsin [Taïwan] ; Chan-Hua Chang [Taïwan] ; Chi-You Chang [Taïwan] ; Wei-Hao Peng [Taïwan] ; Chung-Liang Chien [Taïwan] ; Ming-Fu Chang [Taïwan] ; Shin C. Chang [Taïwan] | Nucleocapsid protein-dependent assembly of the RNA packaging signal of Middle East respiratory syndrome coronavirus. |
000C57 (2018) |
Jian Lei [Allemagne] ; Yuri Kusov [Allemagne] ; Rolf Hilgenfeld [Allemagne] | Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein. |
000C59 (2018) |
Luca Sancineto [Pologne] ; Nunzio Iraci [Italie] ; Oriana Tabarrini [Italie] ; Claudio Santi [Italie] | NCp7: targeting a multitasking protein for next-generation anti-HIV drug development part 1: covalent inhibitors. |
000C74 (2018) |
Si Min Zhang [Singapour, Suède] ; Ying Liao [République populaire de Chine] ; Tuan Ling Neo [Singapour] ; Yanning Lu [Singapour] ; Ding Xiang Liu [Singapour] ; Anders Vahlne [Suède] ; James P. Tam [Singapour] | Identification and application of self-binding zipper-like sequences in SARS-CoV spike protein |
000C99 (2018) |
Lei Yan [République populaire de Chine] ; Bing Meng [République populaire de Chine] ; Jiangchao Xiang [République populaire de Chine] ; Ian A. Wilson [République populaire de Chine] ; Bei Yang [République populaire de Chine] | Crystal structure of the post-fusion core of the Human coronavirus 229E spike protein at 1.86 Å resolution. |
000D02 (2018) |
Jeanne M. Sisk [États-Unis] ; Matthew B. Frieman [États-Unis] ; Carolyn E. Machamer [États-Unis] | Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors. |
000D52 (2017) |
Matthew E. Grunewald ; Anthony R. Fehr ; Jeremiah Athmer ; Stanley Perlman | The coronavirus nucleocapsid protein is ADP-ribosylated |
000D64 (2017) |
Anirban Ghosh ; Dipita Bhattacharyya ; Anirban Bhunia | Structural insights of a self-assembling 9-residue peptide from the C-terminal tail of the SARS corona virus E-protein in DPC and SDS micelles: A combined high and low resolution spectroscopic study |
000D89 (2017) |
Su-Hua Huang [Taïwan] ; Tzu-Ying Lee [Taïwan] ; Ying-Ju Lin [Taïwan] ; Lei Wan [Taïwan] ; Chih-Ho Lai [Taïwan] ; Cheng-Wen Lin [Taïwan] | Phage display technique identifies the interaction of severe acute respiratory syndrome coronavirus open reading frame 6 protein with nuclear pore complex interacting protein NPIPB3 in modulating Type I interferon antagonism. |
000E02 (2017) |
Mukesh Mahajan ; Deepak Chatterjee ; Kannaian Bhuvaneswari ; Shubhadra Pillay ; Surajit Bhattacharjya | NMR structure and localization of a large fragment of the SARS-CoV fusion protein: Implications in viral cell fusion |
000E04 (2017) |
Manal Alfuwaires ; Abdallah Altaher ; Mahmoud Kandeel | Molecular Dynamic Studies of Interferon and Innate Immunity Resistance in MERS CoV Non-Structural Protein 3. |
000E06 (2017) |
Vineet D. Menachery [États-Unis] ; Lisa E. Gralinski [États-Unis] ; Hugh D. Mitchell [États-Unis] ; Kenneth H. Dinnon [États-Unis] ; Sarah R. Leist [États-Unis] ; Boyd L. Yount [États-Unis] ; Rachel L. Graham [États-Unis] ; Eileen T. Mcanarney [États-Unis] ; Kelly G. Stratton [États-Unis] ; Adam S. Cockrell [États-Unis] ; Kari Debbink [États-Unis] ; Amy C. Sims [États-Unis] ; Katrina M. Waters [États-Unis] ; Ralph S. Baric [États-Unis] | Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis |
000E55 (2017) |
Lennart Michel Reinke [Allemagne] ; Martin Spiegel [Allemagne] ; Teresa Plegge [Allemagne] ; Anika Hartleib [Allemagne] ; Inga Nehlmeier [Allemagne] ; Stefanie Gierer [Allemagne] ; Markus Hoffmann [Allemagne] ; Heike Hofmann-Winkler [Allemagne] ; Michael Winkler [Allemagne] ; Stefan Pöhlmann [Allemagne] | Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2. |
000E56 (2017) |
Jibin Sadasivan [Inde] ; Manmeet Singh ; Jayasri Das Sarma | Cytoplasmic tail of coronavirus spike protein has intracellular targeting signals. |
000E61 (2017) |
Leonardo Vazquez [Brésil] ; Luis Mauricio Trambaioli Da Rocha E Lima [Brésil] ; Marcius Da Silva Almeida [Brésil] | Comprehensive structural analysis of designed incomplete polypeptide chains of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus. |
000E64 (2017) |
Janet To [Singapour] ; Wahyu Surya [Singapour] ; To Sing Fung [Singapour] ; Yan Li [Singapour] ; Carmina Verdià-Bàguena [Espagne] ; Maria Queralt-Martin [Espagne] ; Vicente M. Aguilella [Espagne] ; Ding Xiang Liu [Singapour] ; Jaume Torres [Singapour] | Channel-Inactivating Mutations and Their Revertant Mutants in the Envelope Protein of Infectious Bronchitis Virus. |
000E77 (2017) |
Lisa E. Gralinski [États-Unis] ; Vineet D. Menachery [États-Unis] ; Andrew P. Morgan [États-Unis] ; Allison L. Totura [États-Unis] ; Anne Beall [États-Unis] ; Jacob Kocher [États-Unis] ; Jessica Plante [États-Unis] ; D. Corinne Harrison-Shostak [États-Unis] ; Alexandra Sch Fer [États-Unis] ; Fernando Pardo-Manuel De Villena [États-Unis] ; Martin T. Ferris [États-Unis] ; Ralph S. Baric [États-Unis] | Allelic Variation in the Toll-Like Receptor Adaptor Protein Ticam2 Contributes to SARS-Coronavirus Pathogenesis in Mice |
000F27 (2016) |
Makoto Ujike ; Cheng Huang ; Kazuya Shirato ; Shinji Makino ; Fumihiro Taguchi | The contribution of the cytoplasmic retrieval signal of severe acute respiratory syndrome coronavirus to intracellular accumulation of S proteins and incorporation of S protein into virus-like particles |
000F57 (2016) |
Canping Huang [République populaire de Chine] ; Jianxun Qi [République populaire de Chine] ; Guangwen Lu [République populaire de Chine] ; Qihui Wang [République populaire de Chine] ; Yuan Yuan [République populaire de Chine] ; Ying Wu [République populaire de Chine] ; Yanfang Zhang [République populaire de Chine] ; Jinghua Yan [République populaire de Chine] ; George F. Gao [République populaire de Chine] | Putative Receptor Binding Domain of Bat-Derived Coronavirus
HKU9 Spike Protein: Evolution of Betacoronavirus Receptor Binding
Motifs |
000F61 (2016) |
Robert N. Kirchdoerfer [États-Unis] ; Christopher A. Cottrell [États-Unis] ; Nianshuang Wang [États-Unis] ; Jesper Pallesen [États-Unis] ; Hadi M. Yassine [États-Unis] ; Hannah L. Turner [États-Unis] ; Kizzmekia S. Corbett [États-Unis] ; Barney S. Graham [États-Unis] ; Jason S. Mclellan [États-Unis] ; Andrew B. Ward [États-Unis] | Pre-fusion structure of a human coronavirus spike protein. |
000F85 (2016) |
Pak-Yin Lui [République populaire de Chine] ; Lok-Yin Roy Wong [République populaire de Chine] ; Cheuk-Lai Fung [République populaire de Chine] ; Kam-Leung Siu [République populaire de Chine] ; Man-Lung Yeung [République populaire de Chine] ; Kit-San Yuen [République populaire de Chine] ; Chi-Ping Chan [République populaire de Chine] ; Patrick Chiu-Yat Woo [République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine] ; Dong-Yan Jin [République populaire de Chine] | Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3. |
000F88 (2016) |
Joshua M. Thornbrough [États-Unis] ; Babal K. Jha [États-Unis] ; Boyd Yount [États-Unis] ; Stephen A. Goldstein [États-Unis] ; Yize Li [États-Unis] ; Ruth Elliott [États-Unis] ; Amy C. Sims [États-Unis] ; Ralph S. Baric [États-Unis] ; Robert H. Silverman [États-Unis] ; Susan R. Weiss [États-Unis] | Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation. |
000F92 (2016) |
Huib H. Rabouw [Pays-Bas] ; Martijn A. Langereis [Pays-Bas] ; Robert C. M. Knaap [Pays-Bas] ; Tim J. Dalebout [Pays-Bas] ; Javier Canton [Espagne] ; Isabel Sola [Espagne] ; Luis Enjuanes [Espagne] ; Peter J. Bredenbeek [Pays-Bas] ; Marjolein Kikkert [Pays-Bas] ; Raoul J. De Groot [Pays-Bas] ; Frank J. M. Van Kuppeveld [Pays-Bas] | Middle East Respiratory Coronavirus Accessory Protein 4a Inhibits PKR-Mediated Antiviral Stress Responses |
000F99 (2016) |
Xin Hu [États-Unis] ; Jaimee R. Compton [États-Unis] ; Dagmar H. Leary [États-Unis] ; Mark A. Olson [États-Unis] ; Michael S. Lee [États-Unis] ; Jonah Cheung [États-Unis] ; Wenjuan Ye [États-Unis] ; Mark Ferrer [États-Unis] ; Noel Southall [États-Unis] ; Ajit Jadhav [États-Unis] ; Elaine M. Morazzani [États-Unis] ; Pamela J. Glass [États-Unis] ; Juan Marugan [États-Unis] ; Patricia M. Legler [États-Unis] | Kinetic, Mutational, and Structural Studies of the Venezuelan Equine Encephalitis Virus Nonstructural Protein 2 Cysteine Protease. |
001004 (2016) |
Joeri Kint [Pays-Bas] ; Martijn A. Langereis [Pays-Bas] ; Helena J. Maier [Royaume-Uni] ; Paul Britton [Royaume-Uni] ; Frank J. Van Kuppeveld [Pays-Bas] ; Joseph Koumans [Pays-Bas] ; Geert F. Wiegertjes [Pays-Bas] ; Maria Forlenza [Pays-Bas] | Infectious Bronchitis Coronavirus Limits Interferon Production by Inducing a Host Shutoff That Requires Accessory Protein 5b. |
001044 (2016) |
Clifton Mcpherson [États-Unis] ; Richard Chubet [États-Unis] ; Kathy Holtz [États-Unis] ; Yoshikazu Honda-Okubo [Australie] ; Dale Barnard [États-Unis] ; Manon Cox [États-Unis] ; Nikolai Petrovsky [Australie] | Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant. |